|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 12, 2006
doi: 10.1242/10.1242/dev.02223
,
,
1 Laboratory of Molecular Neurobiology, MBB, Karolinska Institutet,
Scheelesväg 1, Retzius building A1, 17 177 Stockholm, Sweden.
2 Division of Molecular Neurobiology, MRC National Institute for Medical
Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
3 Division of Developmental Neurobiology, MRC National Institute for Medical
Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
Authors for correspondence (e-mail:
Ernest.Arenas{at}mbb.ki.se
and
sang{at}nimr.mrc.ac.uk)
Accepted 25 November 2005
Proneural genes are crucial regulators of neurogenesis and subtype specification in many areas of the nervous system; however, their function in dopaminergic neuron development is unknown. We report that proneural genes have an intricate pattern of expression in the ventricular zone of the ventral midbrain, where mesencephalic dopaminergic neurons are generated. Neurogenin 2 (Ngn2) and Mash1 are expressed in the ventral midline, while Ngn1, Ngn2 and Mash1 are co-localized more laterally in the ventricular zone. Ngn2 is also expressed in an intermediate zone immediately adjacent to the ventricular zone at the ventral midline. To examine the function of these genes, we analyzed mutant mice in which one or two of these genes were deleted (Ngn1, Ngn2 and Mash1) or substituted (Mash1 in the Ngn2 locus). Our results demonstrate that Ngn2 is required for the differentiation of Sox2+ ventricular zone progenitors into Nurr1+ postmitotic dopaminergic neuron precursors in the intermediate zone, and that it is also likely to be required for their subsequent differentiation into tyrosine hydroxylase-positive dopaminergic neurons in the marginal zone. Although Mash1 normally has no detectable function in dopaminergic neuron development, it could partially rescue the generation of dopaminergic neuron precursors in the absence of Ngn2. These results demonstrate that Ngn2 is uniquely required for the development of midbrain dopaminergic neurons.
Key words: Proneural genes, Cell fate specification, Differentiation, Sox2, Nurr1, Stem cells, Parkinson's disease
This article has been cited by other articles:
|
|
 |
|
  S. J. Hong, T. Lardaro, M. S. Oh, Y. Huh, Y. Ding, U. J. Kang, J. Kirfel, R. Buettner, and K.-S. Kim Regulation of the Noradrenaline Neurotransmitter Phenotype by the Transcription Factor AP-2{beta} J. Biol. Chem., June 13, 2008; 283(24): 16860 - 16867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Roybon, T. Hjalt, N. S. Christophersen, J.-Y. Li, and P. Brundin Effects on Differentiation of Embryonic Ventral Midbrain Progenitors by Lmx1a, Msx1, Ngn2, and Pitx3 J. Neurosci., April 2, 2008; 28(14): 3644 - 3656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mattar, L. M. Langevin, K. Markham, N. Klenin, S. Shivji, D. Zinyk, and C. Schuurmans Basic Helix-Loop-Helix Transcription Factors Cooperate To Specify a Cortical Projection Neuron Identity Mol. Cell. Biol., March 1, 2008; 28(5): 1456 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ledda, O. Bieraugel, S. S. Fard, M. Vilar, and G. Paratcha Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF J. Neurosci., January 2, 2008; 28(1): 39 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ono, T. Nakatani, Y. Sakamoto, E. Mizuhara, Y. Minaki, M. Kumai, A. Hamaguchi, M. Nishimura, Y. Inoue, H. Hayashi, et al. Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells Development, September 1, 2007; 134(17): 3213 - 3225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Saarimaki-Vire, P. Peltopuro, L. Lahti, T. Naserke, A. A. Blak, D. M. Vogt Weisenhorn, K. Yu, D. M. Ornitz, W. Wurst, and J. Partanen Fibroblast Growth Factor Receptors Cooperate to Regulate Neural Progenitor Properties in the Developing Midbrain and Hindbrain J. Neurosci., August 8, 2007; 27(32): 8581 - 8592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Berninger, M. R. Costa, U. Koch, T. Schroeder, B. Sutor, B. Grothe, and M. Gotz Functional Properties of Neurons Derived from In Vitro Reprogrammed Postnatal Astroglia J. Neurosci., August 8, 2007; 27(32): 8654 - 8664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. M. Ferri, W. Lin, Y. E. Mavromatakis, J. C. Wang, H. Sasaki, J. A. Whitsett, and S.-L. Ang Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner Development, August 1, 2007; 134(15): 2761 - 2769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakatani, Y. Minaki, M. Kumai, and Y. Ono Helt determines GABAergic over glutamatergic neuronal fate by repressing Ngn genes in the developing mesencephalon Development, August 1, 2007; 134(15): 2783 - 2793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Park, J. S. Kang, Y. H. Shin, M.-Y. Chang, S. Chung, H.-C. Koh, M. H. Zhu, S. B. Oh, Y.-S. Lee, G. Panagiotakos, et al. Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons FASEB J, December 1, 2006; 20(14): 2553 - 2555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-L. Ang Transcriptional control of midbrain dopaminergic neuron development Development, September 15, 2006; 133(18): 3499 - 3506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ma Transcriptional regulation of neuronal phenotype in mammals J. Physiol., September 1, 2006; 575(2): 379 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Prakash and W. Wurst Genetic networks controlling the development of midbrain dopaminergic neurons J. Physiol., September 1, 2006; 575(2): 403 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Andersson, J. B. Jensen, M. Parmar, F. Guillemot, and A. Bjorklund Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2 Development, February 1, 2006; 133(3): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
